Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Merck -- Ignore unavailable to you. Want to Upgrade?

To: Alfred W. Post who wrote (1352)	7/10/2002 6:50:27 PM
From: sea_biscuit	Read Replies (2) \| Respond to of 1580

Merck is approaching historically undervalued levels here. If it hits 40, then it will have a dividend yield of 3.5% and should be an attractive buy there. Yet I am so SCARED to buy anything these days. Looks like we can't trust any number anywhere. I expected Merck to be particularly squeaky clean and it has come as a major disappointment. I would rather that these levels had come as a result of a general market sell-off instead of due to problems with Merck's accounting. I am terribly disappointed. Not to mention disgusted.